ID   CL1DNEO
AC   CVCL_E3EY
RX   PubMed=2128461;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Transposon Tn5 neo.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F739 ! L-M(TK-)1D
SX   Male
AG   100D
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
RX   PubMed=2128461;
RA   Angrand P.-O., Kallenbach S., Weiss M.C., Rousset J.-P.;
RT   "An exogenous albumin promoter can become silent in dedifferentiated
RT   hepatoma variants as well as intertypic hybrids.";
RL   Cell Growth Differ. 1:519-526(1990).
//